The variance seen in the ROHHAD subjects for ADORA2A protein expression, as well as PHACTR1, is likely due to the spectrum of ROHHAD symptomology that unfolds across time and with varying severity. This evidence concerns the gene PHACTR1 and rapid-onset childhood obesity-hypothalamic dysfunction-hypoventilation-autonomic dysregulation syndrome.